e8va12b
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
INVERNESS MEDICAL INNOVATIONS, INC.
See Table of Additional Registrants Below
(Exact name of registrant as specified in its charter)
     
Delaware   04-3565120
     
(State or other jurisdiction of incorporation)   (IRS Employer Identification No.)
     
51 Sawyer Road, Suite 200    
Waltham, MA   02453
     
(Address of principal executive offices)   (Zip Code)
Securities to be registered pursuant to Section 12(b) of the Act:
     
Title of each class   Name of each exchange on which
to be so registered   each class is to be registered
9.00% Senior Subordinated Notes due 2016
and guarantees thereof 		  New York Stock Exchange
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. þ
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. o
Securities Act registration statement file number to which this form relates: 333-158542
Securities to be registered pursuant to Section 12(g) of the Act: None
 
 

 

 

TABLE OF ADDITIONAL REGISTRANTS
     The address, including zip code, of each of the co-registrants is 51 Sawyer Road, Suite 200, Waltham, Massachusetts, 02453.
         
    State or other    
    jurisdiction of    
Exact name of additional registrant   incorporation or   I.R.S. Employer
as specified in its charter   organization   Identification Number
Advantage Diagnostics Corporation
  Delaware   20-1247157
Alere LLC
  Delaware   26-2564744
Alere Healthcare of Illinois, Inc.
  Georgia   58-2068880
Alere Health Improvement Company
  Delaware   23-2776413
Alere Health Systems, Inc.
  Delaware   22-3493126
Alere Medical, Inc.
  California   94-3238845
Alere Wellology, Inc.
  Delaware   54-1776557
Alere Women’s and Children’s Health, LLC
  Delaware   58-2205984
Ameditech Inc.
  California   33-0859551
Applied Biotech, Inc.
  California   33-0447325
Binax, Inc.
  Delaware   20-2507302
Biosite Incorporated
  Delaware   33-0288606
Cholestech Corporation
  Delaware   94-3065493
First Check Diagnostics Corp.
  Delaware   20-8329751
First Check Ecom, Inc.
  Massachusetts   33-1026518
Forefront Diagnostics, Inc.
  California   33-0733551
Hemosense, Inc.
  Delaware   77-0452938
IM US Holdings, LLC
  Delaware   26-0349667
Innovacon, Inc.
  Delaware   20-1100264
Innovations Research, LLC
  Delaware   20-0653511
Innovative Mobility, LLC
  Florida   20-0351538
Instant Technologies, Inc.
  Virginia   54-1837621
Inverness Medical, LLC
  Delaware   26-0392649
Inverness Medical — Biostar Inc.
  Delaware   91-1929582
Inverness Medical Innovations North America, Inc.
  Delaware   26-1444559
Inverness Medical International Holding Corp.
  Delaware   80-0077873
Inverness Medical International Holding Corp. II
  Delaware   20-0963463
Ischemia Technologies, Inc.
  Delaware   84-1489537
IVC Industries, Inc.
  Delaware   22-1567481
Matritech, Inc.
  Delaware   26-1436477
Ostex International, Inc.
  Washington   91-1450247
Quality Assured Services, Inc.
  Florida   59-3437644
Redwood Toxicology Laboratory, Inc.
  California   68-0332937
RTL Holdings, Inc.
  Delaware   20-4371685
Selfcare Technology, Inc.
  Delaware   04-3383533
Wampole Laboratories, LLC
  Delaware   37-1485678

2

 

Item 1.   Description of Registrant’s Securities to be Registered.
     The description of the 9.00% senior subordinated notes due 2016 (the “Notes”) of Inverness Medical Innovations, Inc. (“Inverness”), and the related guarantees of the co-registrant guarantor subsidiaries of Inverness, to be registered hereunder is set forth under (a) the section captioned “Description of Debt Securities and Subsidiary Guarantees We May Offer” in the registrants’ prospectus dated May 1, 2009 (the “Base Prospectus”) filed on May 4, 2009 pursuant to Rule 424(b) under the Securities Act of 1933, as amended, which is a part of the registrants’ registration statement on Form S-3 (No. 333-158542), as supplemented by (b) the section captioned “Description of Notes” in the registrants’ prospectus supplement dated May 7, 2009 filed on May 8, 2009 pursuant to Rule 424(b) under the Securities Act of 1933, as amended, which descriptions are incorporated by reference into this registration statement and deemed to be a part hereof.
Item 2.   Exhibits.
         
  3.1    
Amended and Restated Certificate of Incorporation of Inverness Medical Innovations, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Annual Report on Form 10-K, as amended, for the year ended December 31, 2001)
  3.2    
First Amendment to the Amended and Restated Certificate of Incorporation of Inverness Medical Innovations, Inc. (incorporated by reference to Exhibit 3.4 to Company’s Annual Report on Form 10-K, as amended, for the year ended December 31, 2007)
  3.3    
Second Amendment to the Amended and Restated Certificate of Incorporation of Inverness Medical Innovations, Inc. (incorporated by reference to Exhibit 3.3 to Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2008)
  3.4    
Certificate of Designation, Preferences and Rights of Series A Convertible Preferred Stock of Inverness Medical Innovations, Inc. (incorporated by reference to Exhibit 99.2 to the Company’s Current Report on Form 8-K dated December 20, 2001)
  3.5    
Certificate of Designations of Series B Convertible Perpetual Preferred Stock of Inverness Medical Innovations, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, event date, May 9, 2008, filed on May 14, 2008)
  3.6    
Certificate of Elimination of Series A Convertible Preferred Stock of Inverness Medical Innovations, Inc. (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K, event date, May 9, 2008, filed on May 14, 2008)
  3.7    
Certificate of Correction to the First Amendment to the Amended and Restated Certificate of Incorporation of Inverness Medical Innovations, Inc. (incorporated by reference to Exhibit 3.5 to the Company’s Annual Report on Form 10-K, as amended, for the year ended December 30, 2006)
  3.8    
Second Certificate of Correction to the First Amendment to the Amended and Restated Certificate of Incorporation of Inverness Medical Innovations, Inc. (incorporated by reference to Exhibit 3.5 to Company’s Registration Statement on Form S-4, as amended (File 333-149259))
  3.9    
Amended and Restated By-laws of Inverness Medical Innovations, Inc. (incorporated by reference to Exhibit 3.3 to the Company’s Annual Report on Form 10-K, as amended, for the year ended December 31, 2001)
  4.1    
Indenture dated as of May 12, 2009 among Inverness Medical Innovations, Inc., as issuer, and U.S. Bank National Association, as trustee (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K dated May 12, 2009)
  4.2    
First Supplemental Indenture dated as of May 12, 2009 among Inverness Medical Innovations, Inc., as issuer, the co-registrant guarantor subsidiaries, as guarantors, and U.S. Bank National Association, as trustee (incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K dated May 12, 2009)
  4.3    
Form of 9.00% Senior Subordinated Note due 2016 of Inverness Medical Innovations, Inc. (included in Exhibit 4.2 above)

3

 

SIGNATURE
          Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrants have duly caused this registration statement to be signed on their behalf by the undersigned, thereunto duly authorized.
                 
    Registrants:    
 
                
 
                
    INVERNESS MEDICAL INNOVATIONS, INC.    
 
                
    By:   /s/ David A. Teitel    
             
 
      Name:   David A. Teitel    
 
      Title:   Chief Financial Officer    
 
                
 
                
   
ADVANTAGE DIAGNOSTICS CORPORATION
    
   
ALERE LLC
    
   
ALERE HEALTHCARE OF ILLINOIS, INC.
    
   
ALERE HEALTH IMPROVEMENT COMPANY
    
   
ALERE HEALTH SYSTEMS, INC.
    
   
ALERE MEDICAL, INC.
    
   
ALERE WELLOLOGY, INC.
    
   
ALERE WOMEN’S AND CHILDREN’S HEALTH, LLC
    
   
AMEDITECH INC.
    
   
APPLIED BIOTECH, INC.
    
   
BINAX, INC.
    
   
BIOSITE INCORPORATED
    
 
                
 
                
    By:   /s/ David A. Teitel    
             
 
      Name:   David A. Teitel    
       
Title (respectively): Vice President, Finance; Vice President and Treasurer; Vice President, Finance; Vice President, Finance; Vice President and Treasurer; Vice President and Treasurer; Vice President, Finance; Vice President, Finance; General Manager; Vice President; Vice President, Finance; Vice President, Finance
    
 
                
 
                
   
CHOLESTECH CORPORATION
    
   
FIRST CHECK DIAGNOSTICS CORP.
    
   
FIRST CHECK ECOM, INC.
    
   
FOREFRONT DIAGNOSTICS, INC.
    
   
HEMOSENSE, INC.
    
   
IM US HOLDINGS, LLC
    

4

 

                 
   
INNOVACON, INC.
    
   
INNOVATIONS RESEARCH, LLC
    
   
INNOVATIVE MOBILITY, LLC
    
   
INSTANT TECHNOLOGIES, INC.
    
   
INVERNESS MEDICAL, LLC
    
   
INVERNESS MEDICAL — BIOSTAR INC.
    
 
                
 
                
    By:   /s/ David A. Teitel    
             
 
      Name:   David A. Teitel    
       
Title (respectively): Vice President, Finance and Chief Financial Officer; Vice President, Finance; Vice President; Vice President; Treasurer; President; Vice President, Finance; Vice President, Finance; Chief Financial Officer; Vice President, Finance; Vice President, Finance; Vice President, Finance
    
 
                
 
                
   
INVERNESS MEDICAL INNOVATIONS NORTH AMERICA, INC.
    
   
INVERNESS MEDICAL INTERNATIONAL HOLDING CORP.
    
   
INVERNESS MEDICAL INTERNATIONAL HOLDING CORP. II
    
   
ISCHEMIA TECHNOLOGIES, INC.
    
   
IVC INDUSTRIES, INC.
    
   
MATRITECH, INC.
    
   
OSTEX INTERNATIONAL, INC.
    
   
QUALITY ASSURED SERVICES, INC.
    
   
REDWOOD TOXICOLOGY LABORATORY, INC.
    
   
RTL HOLDINGS, INC.
    
   
SELFCARE TECHNOLOGY, INC.
    
   
WAMPOLE LABORATORIES, LLC
    
 
                
 
                
    By:   /s/ David A. Teitel    
             
 
      Name:   David A. Teitel    
       
Title (respectively): Vice President, Finance; President; President; Vice President, Finance; Vice President; Vice President, Finance; Vice President, Finance; Chief Financial Officer; Vice President, Finance; Vice President, Finance; Vice President, Finance; Vice President
    
Date: May 12, 2009

5